drugset / Trial / NCT00128583
Vaccine Therapy in Treating Patients With Malignant Melanoma
Open-labelTreatment
Summary
RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with malignant melanoma.
Timeline
- Start
- 2005-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Canvaxin | Vaccine | — | Subcutaneous |